Evaluating indirect survey question methods on reproductive health behavior

生殖健康行为间接调查问题法评价

基本信息

  • 批准号:
    10810569
  • 负责人:
  • 金额:
    $ 45.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-26 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary: "Evaluating indirect survey question methods on reproductive health behavior" Abortion is a major component of reproductive health and autonomy, but is increasingly subject to access restrictions that may dramatically reduce utilization. Beyond general aggregate statistics, little is known about the characteristics, attitudes, and behaviors of those obtaining abortions at the state and national levels. A lack of validity of direct survey questions is a critical barrier to understanding attitudes and characteristics of abortion patients. Indirect survey question methods have the potential to overcome this barrier. The indirect methods known as the Item Count Technique (ICT) and the Item Sum Technique (IST) estimate respectively whether and how many abortions a woman has experienced. In this study, we evaluate the ICT and IST methods using data from nine states with more and less restrictive abortion policies, in periods when abortion was more and less restricted. The nine states are located in the Mid- Atlantic, Midwestern, Southwestern, and Southeastern regions of the US. The study aims are to: 1) Evaluate ICT and IST internal validity assumptions; 2) Evaluate bias of the estimators from ICT and IST against external abortion statistics from CDC reports and the Guttmacher Institute’s periodic census of abortion providers by state and by age and race/ethnicity; 3) Evaluate the performance of different implementations of multivariate regression estimation of abortion on socio-demographic characteristics and assess sampling-variance gains to incorporating external abortion count data in combined survey and population data estimators; and 4) Estimate differences in incidence and mean numbers of abortions by state policy and by respondent characteristics not readily available in administrative records and provider surveys. Methodologically, our study will contribute to existing literature by evaluating ICT method for abortion to a broad social-geographic range U.S. states, by evaluating for the first time anywhere the validity of the IST method applied to numbers of abortions, and by evaluating the validity of the ICT and IST methods over a limited period, specifically five years. Substantively, we will contribute to understanding characteristics, attitudes, and behaviors of those seeking and obtaining abortions across nine U.S. states both before and after the major state policy changes of 2022.
项目摘要:“评估生殖健康间接调查问题方法” 健康行为” 堕胎是生殖健康和自主权的一个主要组成部分,但越来越受到 访问可能会大大降低利用率的限制。超过一般总量 统计,很少有人知道的特点,态度,和行为的那些获得 在州和国家一级实施堕胎。直接调查问题缺乏有效性是一个关键 对堕胎病人的态度和特点的理解障碍。间接测量 提问方法有可能克服这一障碍。间接方法称为 项目计数技术(ICT)和项目总和技术(IST)分别估计 一个女人是否经历过堕胎以及经历过多少次堕胎。在这项研究中,我们评估了ICT 和IST方法,使用来自9个州的数据,这些州的堕胎政策限制性或多或少, 堕胎受到越来越多的限制。这九个国家位于中部, 美国的大西洋、中西部、西南部和东南部地区。研究的目的是: 1)评估ICT和IST内部有效性假设; 2)评估估计量的偏倚, 信息和通信技术和信息技术与疾病预防控制中心报告和古特马赫的外部堕胎统计数据的对比 研究所按州、年龄和种族/族裔对堕胎提供者进行的定期普查; 3) 评估多元回归估计的不同实现的性能, 堕胎对社会人口特征的影响,并评估抽样方差收益, 将外部堕胎计数数据纳入合并调查和人口数据估计数; 和4)按国家政策和国家政策估计堕胎发生率和平均数的差异。 在行政记录和提供者调查中不容易获得的答复者特征。 在方法上,我们的研究将有助于现有的文献,通过评估ICT方法, 堕胎到广泛的社会地理范围美国各州,通过评估第一次在任何地方 IST方法应用于流产数量的有效性,并通过评估 在有限的时间内,特别是五年内,使用ICT和IST方法。实质上,我们将 有助于了解那些寻求和 在主要的州政策变化之前和之后, 2022年。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Heide Marie Jackson其他文献

Heide Marie Jackson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Heide Marie Jackson', 18)}}的其他基金

Development of methods to assess geographic variation in reproductive health behaviors and outcomes over the life course
开发评估生命历程中生殖健康行为和结果的地理差异的方法
  • 批准号:
    10732184
  • 财政年份:
    2023
  • 资助金额:
    $ 45.14万
  • 项目类别:
Sci-Tech Core-Maryland Population Research Center
科技核心-马里兰州人口研究中心
  • 批准号:
    10478246
  • 财政年份:
    2001
  • 资助金额:
    $ 45.14万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 45.14万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 45.14万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 45.14万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 45.14万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 45.14万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 45.14万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 45.14万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 45.14万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 45.14万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 45.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了